Parallel Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Parallel Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.5K	Buy	4,048 +3,997	+7,837%	+$15.9K	﹤0.01%	2605
2025 Q4	$179	Sell	51 -228	-82%	-$781	﹤0.01%	3521
2025 Q3	$910	Buy	279 +49	+21%	+$154	﹤0.01%	3245
2025 Q2	$564	Sell	230 -802	-78%	-$4.06K	﹤0.01%	3293
2025 Q1	$6.88K	Buy	1,032 +44	+4%	+$435	﹤0.01%	2573
2024 Q4	$12.4K	Buy	988 +929	+1,575%	+$14K	﹤0.01%	2342
2024 Q3	$1.09K	Buy	+59	New	+$1.21K	﹤0.01%	3012
2022 Q2	–	Sell	-293	Closed	-$5K	–	3307
2022 Q1	$5K	Buy	+293	New	+$5.06K	﹤0.01%	2315
2021 Q4	–	Sell	-93	Closed	-$3K	–	3266
2021 Q3	$3K	Sell	93 -50	-35%	-$1.82K	﹤0.01%	2589
2021 Q2	$6K	Buy	143 +128	+853%	+$5.56K	﹤0.01%	2245
2021 Q1	$1K	Buy	+15	New	+$824	﹤0.01%	2678

Other funds holding RCKT

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Citigroup New York $157B AUM 32.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return